Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma

Journal:

Science

Published:

2026-03-12

DOI:

10.1126/science.aec7929

Affiliations:

8

Authors:

19

Go to article

Institutions	Authors	Share
Abramson Cancer Center, Penn, United States of America (USA)	10.500000 10.500000	0.55
University of Pennsylvania (Penn), United States of America (USA)	3.500000	0.18
Johns Hopkins University (JHU), United States of America (USA)	3.000000	0.16
Revolution Medicines, United States of America (USA)	2.000000	0.11

Interested in Oncology and Carcinogenesis?